Compare AVO & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVO | BBNX |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 997.9M |
| IPO Year | 2020 | 2025 |
| Metric | AVO | BBNX |
|---|---|---|
| Price | $13.06 | $19.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $16.50 | ★ $23.28 |
| AVG Volume (30 Days) | 737.9K | ★ 1.3M |
| Earning Date | 09-08-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.92 | ★ 78.95 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,391,200,000.00 | $100,251,000.00 |
| Revenue This Year | $4.52 | $25.74 |
| Revenue Next Year | $15.31 | $44.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 12.68 | ★ 53.94 |
| 52 Week Low | $10.07 | $8.80 |
| 52 Week High | $15.53 | $32.71 |
| Indicator | AVO | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 54.07 | 47.73 |
| Support Level | $13.03 | $12.45 |
| Resistance Level | $13.37 | $20.48 |
| Average True Range (ATR) | 0.46 | 1.68 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 62.41 | 48.07 |
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.